Jianrui song

Dr. Jianrui song

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JSJianrui song
Jianrui song
YZYanling Zhang
Yanling Zhang
RFRyan A. Frieler
Ryan A. Frieler
AAAnthony Andren
Anthony Andren
SWSherri Wood
Sherri Wood
DGDaniel R. Goldstein
Daniel R. Goldstein
Itaconate has emerged as a critical immunoregulatory metabolite. Here, we examined the therapeutic potential of itaconate in atherosclerosis. We found that both itaconate and the enzyme that synthesizes it, aconitate decarboxylase 1 (Acod1, also known as immune-responsive gene 1 [IRG1]), are upregulated during atherogenesis in mice. Deletion of Acod1 in myeloid cells exacerbated inflammation and atherosclerosis in vivo and resulted in an elevated frequency of a specific subset of M1-polarized proinflammatory macrophages in the atherosclerotic aorta. Importantly, Acod1 levels were inversely correlated with clinical occlusion in atherosclerotic human aorta specimens. Treating mice with the itaconate derivative 4-octyl itaconate attenuated inflammation and atherosclerosis induced by high cholesterol. Mechanistically, we found that the antioxidant transcription factor, nuclear factor erythroid 2–related factor 2 (Nrf2), was required for itaconate to suppress macrophage activation induced by oxidized lipids in vitro and to decrease atherosclerotic lesion areas in vivo. Overall, our work shows that itaconate suppresses atherogenesis by inducing Nrf2-dependent inhibition of proinflammatory responses in macrophages. Activation of the itaconate pathway may represent an important approach to treat atherosclerosis.

30 August 2021 in Mechanisms of Ageing and Development
Verified
Journal Article
Closed access
MVMita Varghese
Mita Varghese
JSJianrui song
Jianrui song
KSKanakadurga Singer
Kanakadurga Singer

23 January 2023 in Aging Cell
Verified
Journal Article
Open access
JSJianrui song
Jianrui song
DFDiana Farris
Diana Farris
PAPaola Ariza
Paola Ariza
SMSmriti Moorjani
Smriti Moorjani
MVMita Varghese
Mita Varghese
DGDaniel R. Goldstein
Daniel R. Goldstein
Although aging enhances atherosclerosis, we do not know if this occurs via alterations in circulating immune cells, lipid metabolism, vasculature, or adipose tissue. Here, we examined whether aging exerts a direct pro‐atherogenic effect on adipose tissue in mice. After demonstrating that aging augmented the inflammatory profile of visceral but not subcutaneous adipose tissue, we transplanted visceral fat from young or aged mice onto the right carotid artery of Ldlr−/− recipients. Aged fat transplants not only increased atherosclerotic plaque size with increased macrophage numbers in the adjacent carotid artery, but also in distal vascular territories, indicating that aging of the adipose tissue enhances atherosclerosis via secreted factors. By depleting macrophages from the visceral fat, we identified that adipose tissue macrophages are major contributors of the secreted factors. To identify these inflammatory factors, we found that aged fat transplants secreted increased levels of the inflammatory mediators TNFα, CXCL2, and CCL2, which synergized to promote monocyte chemotaxis. Importantly, the combined blockade of these inflammatory mediators impeded the ability of aged fat transplants to enhance atherosclerosis. In conclusion, our study reveals that aging enhances atherosclerosis via increased inflammation of visceral fat. Our study suggests that future therapies targeting the visceral fat may reduce atherosclerosis disease burden in the expanding older population.

1 December 2017 in Experimental Neurology
Verified
Journal Article
Closed access
RFRyan A. Frieler
Ryan A. Frieler
YCYutein Chung
Yutein Chung
CACarolyn G. Ahlers
Carolyn G. Ahlers
GGGeorge Gheordunescu
George Gheordunescu
JSJianrui song
Jianrui song
RMRichard M. Mortensen
Richard M. Mortensen

8 November 2020 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
JSJianrui song
Jianrui song
RFRyan A. Frieler
Ryan A. Frieler
SWSteven E. Whitesall
Steven E. Whitesall
YCYutein Chung
Yutein Chung
TVThomas M. Vigil
Thomas M. Vigil
RMRichard M. Mortensen
Richard M. Mortensen
This study showed, for the first time, the role of endogenous IL4Rα signaling in myeloid cells during cardiac remodeling and the underlying mechanisms. We identified myeloid cells are the critical target cell types of IL4Rα signaling during cardiac remodeling post-MI. Deficiency of myeloid IL4Rα signaling causes deteriorated cardiac function post-MI, due to dysregulated inflammation and insufficient fibrotic remodeling. This study sheds light on the potential of activating myeloid-specific IL4Rα signaling to modify remodeling post-MI. This brings hope to patients with MI and diminishes side effects by cell type-specific instead of whole body treatment.

21 September 2021 in Obesity
Verified
Journal Article
Closed access
PDF file
RFRyan A. Frieler
Ryan A. Frieler
TVThomas M. Vigil
Thomas M. Vigil
JSJianrui song
Jianrui song
CLChristy Leung
Christy Leung
CLCarey N. Lumeng
Carey N. Lumeng
RMRichard M. Mortensen
Richard M. Mortensen